Fortrea Holdings (FTRE) Net Margin (2022 - 2026)
Fortrea Holdings (FTRE) reported Net Margin of 3.71% for Q1 2026, down 303.49% quarter-over-quarter from 1.82% in Q4 2024.
Fortrea Holdings (FTRE) Net Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Net Margin for 4 years, with the latest figure at 3.71% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin changed N/A year-over-year to 3.71%; the trailing twelve-month figure through Mar 2026 stood at 0.87% (up 46.0% YoY), and the FY2024 full-year result was 2.11%, down 234.0% from the prior year.
- Net Margin for Q1 2026 stood at 3.71%, down from 1.82% in the prior quarter.
- The five-year high for Net Margin was 8.37% in Q2 2022, with the low at 5.9% in Q2 2024.
- Historically, Net Margin has averaged 0.18% across 4 years, with a median of 0.27% in 2023.
- Annual changes were most pronounced in 2023 — Net Margin slumped 766 bps — and 2024, when it soared 265 bps.
- Fortrea Holdings' Net Margin stood at 2.71% in 2022, then jumped by 69 bps to 0.83% in 2023, then jumped by 319 bps to 1.82% in 2024, then tumbled by 303 bps to 3.71% in 2026.
- The last three Net Margin figures came in at 3.71% (Q1 2026), 1.82% (Q4 2024), and 1.39% (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -3.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.71% |
| Dec 31, 2024 | 1.82% |
| Sep 30, 2024 | -1.39% |
| Jun 30, 2024 | -5.90% |
| Mar 31, 2024 | -3.20% |
| Dec 31, 2023 | -0.83% |
| Sep 30, 2023 | 0.29% |
| Jun 30, 2023 | 0.80% |
| Mar 31, 2023 | 0.65% |
| Dec 31, 2022 | -2.71% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | 8.37% |